TransMedics Group, Inc.

TMDX · Healthcare · TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage orga…

TransMedics Group, Inc. (TMDX), in the Healthcare sector, has 12 disclosed filings on Paydirt over the trailing twelve months from 8 corporate insiders: 2 purchases and 10 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Sep 11 and filed Sep 14. The most active filer was Edward M Basile with 5 filings.

Add to watchlist

Filings, ttm

2 buys · 10 sells

Traders, ttm

8 insiders

Volume, ttmiDollar value disclosed in the window

$5.9M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Sep 11

Filed Sep 14

ADViAverage daily dollar volume

$78.9M

market data

Share price · 12M

$86.42 (-30.9%)

Adjusted for splits and dividends.

Volume by month

Buys $3.1M Sells $8.9M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

EB Edward M Basile Director 5 filings WH Waleed H Hassanein President & CEO 3 filings TK Tamer I Khayal Chief Commercial Officer 3 filings DW David Weill Director 3 filings GH Gerardo Hernandez Chief Financial Officer 2 filings AR Anil P. Ranganath See remarks 2 filings NC Nicholas Corcoran See remarks 1 filing TG Thomas J. Gunderson Director 1 filing

Recent filings

David WeillPURCHASE Director $109K
1,336 sh × $81.63
Exec Sep 11
Filed Sep 14 · 4:30 PM ET Thomas J. GundersonSALE Director $722K
9,624 sh × $75.06
Exec Jun 15
Filed Jun 17 · 5:30 PM ET David WeillSALE Director $524K
3,571 sh × $146.82
Exec Mar 4
Filed Mar 6 · 5:30 PM ET Stephanie LovellSALE Director $178K
1,193 sh × $149.62
Exec Mar 4
Filed Mar 6 · 5:30 PM ET Nicholas CorcoranSALE See remarks $413K
2,966 sh × $139.12
Exec Mar 2
Filed Mar 4 · 5:30 PM ET Anil P. RanganathSALE See remarks $120K
864 sh × $139.12
Exec Mar 2
Filed Mar 4 · 5:30 PM ET Gerardo HernandezSALE Chief Financial Officer $1.1M
7,236 sh across 2 lots
Exec Mar 4
Filed Mar 4 · 5:30 PM ET Gerardo HernandezSALE Chief Financial Officer $128K
920 sh × $139.62
Exec Dec 4 2025
Filed Dec 5 2025 · 5:30 PM ET David WeillSALE Director $693K
5,000 sh × $138.64
Exec Dec 3 2025
Filed Dec 5 2025 · 5:30 PM ET Anil P. RanganathSALE See remarks $436K
3,000 sh × $145.22
Exec Nov 25 2025
Filed Nov 26 2025 · 5:30 PM ET Waleed H HassaneinPURCHASE President & CEO $1.0M
8,775 sh × $114.00
Exec Nov 17 2025
Filed Nov 18 2025 · 4:30 PM ET Edward M BasileSALE Director $540K
4,142 sh × $130.45
Exec Oct 29 2025
Filed Oct 31 2025 · 5:30 PM ET Waleed H HassaneinPURCHASE President & CEO $2.0M
16,875 sh across 3 lots
Exec Aug 6 2025
Filed Aug 8 2025 · 4:30 PM ET Edward M BasileSALE Director $520K
4,143 sh × $125.51
Exec Aug 4 2025
Filed Aug 5 2025 · 5:30 PM ET Edward M BasileSALE Director $632K
5,000 sh × $126.45
Exec May 27 2025
Filed May 29 2025 · 5:30 PM ET Edward M BasileSALE Director $694K
6,000 sh × $115.63
Exec May 9 2025
Filed May 13 2025 · 5:30 PM ET Tamer I KhayalSALE Chief Commercial Officer $184K
2,407 sh × $76.43
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET Tamer I KhayalSALE Chief Commercial Officer $131K
1,458 sh × $90.04
Exec Nov 11 2024
Filed Nov 13 2024 · 5:30 PM ET Edward M BasileSALE Director $564K
6,750 sh across 2 lots
Exec Nov 5 2024
Filed Nov 7 2024 · 5:30 PM ET Waleed H HassaneinSALE President & CEO $1.1M
8,325 sh across 3 lots
Exec Oct 15 2024
Filed Oct 17 2024 · 5:30 PM ET Tamer I KhayalSALE Chief Commercial Officer $252K
1,723 sh across 2 lots
Exec Oct 1 2024
Filed Oct 3 2024 · 5:30 PM ET Waleed H HassaneinSALE President & CEO $1.2M
7,999 sh across 5 lots
Exec Sep 16 2024
Filed Sep 17 2024 · 5:30 PM ET